Moving Forward by Looking Back
Patrick Elf, Amy Isham, Dario Leoni
History of Pharmacy and Pharmaceuticals October 1, 2023 DOI: 10.3368/hopp.65.1.33 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | Meditation |
| Keywords | Commercialization Public relations Aesthetics Environmental ethics Psychotherapist Marketing |
| Citations | 6 |
| Key points | Argues that the commercialization of psychedelics will likely replicate the problems seen with mindfulness, including separation from spiritual roots, co-optation by neoliberal principles, and cost-cutting alterations to administration. |
Abstract
Abstract Much has been written in the academic and popular press on the positive consequences of psychedelic-induced mental states. Following the disappearance of psychedelic research from the public eye between the 1970s and early 2000s, a second wave of psychedelic research is gaining increasing interest from private sector actors looking to explore commercial opportunities. The commercialization of psychedelic substances will likely have consequences for how they are used, to what ends, and to what degree of efficacy. We reflect on the critiques of commercialized mindfulness and explore how they may apply to the future of commercialized psychedelics. Mindfulness and psychedelics share several qualities, including their often spiritual origins and self-transcendent nature. However, mindfulness has already undergone a period of commercialization and represents a precedent case for imagining the possible outcomes of the commercialization of psychedelics. By considering the problems associated with separating the practice from its spiritual roots, co-optation to reinforce neoliberal principles, and alterations to administration to cut costs, the article demonstrates the tensions that arise when trying to implement practices rooted in enhancing well-being in societies dominated by consumer capitalism.